SCHEMBL9315934

SCHEMBL9315934

CCOC(=O)CC(C[N+](=O)[O-])c1cc2cc(F)ccc2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 2/20 0.39
THRB P10828 2/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 2/20 0.35
TSHR P16473 1/20 0.35
MAOB P27338 2/20 0.34
MAOA P21397 1/20 0.34
FBP1 P09467 1/20 0.34
CA12 O43570 1/20 0.33
CA2 P00918 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9315765 0.89 TAS1R3 (0.41) KDM4ELMNAALDH1A1THRBTP53
SCHEMBL9316716 0.88 ALDH1A1 (0.43) KDM4ELMNAALDH1A1THRBTP53
SCHEMBL9315905 0.87 CA12 (0.42) KDM4ELMNAALDH1A1THRBTP53
SCHEMBL9315814 0.87 TP53 (0.48) KDM4ELMNAALDH1A1THRBTP53
SCHEMBL9315029 0.86 KDM4E (0.40) KDM4ELMNAALDH1A1THRBTP53
SCHEMBL9315780 0.84 LMNA (0.39) KDM4ELMNAALDH1A1THRBTP53
SCHEMBL9315930 0.79 MAPT (0.34) KDM4ELMNAALDH1A1MAPTTSHR
SCHEMBL1269176 0.78 MAPT (0.46) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL20475329 0.78 MAPT (0.41) KDM4ELMNAALDH1A1MAPTTSHR
SCHEMBL1269119 0.76 F10 (0.43) KDM4ELMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed